the NIH is no longer using Rezulin (troglitazone) in their large Diabetes Prevention Study

July 1998

The NIH is no longer using Rezulin (troglitazone) in theirlarge Diabetes Prevention Study.

This study is designed to see if type 2 diabetes can beprevented or delayed...in patients with impaired glucose tolerance.

Researchers were testing 3 treatment arms...diet and exercise,metformin (Glucophage), and troglitazone (Rezulin).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote